Canagliflozin/metformin immediate-release - Johnson & Johnson Innovative Medicine
At a glance
- Drug Originator Janssen Research & Development
- Drug Licenced by Mundipharma Medical Company
- Drug Class Antihyperglycaemics; Biguanides; Glucosides; Small molecules; Thiophenes
- Mechanism of Action AMP activated protein kinase stimulants; Gluconeogenesis inhibitors; Glucose modulators; Sodium-glucose transporter 2 inhibitors
- USA Patent Applicants JANSSEN PHARMS
- USA Patents 22
- NDAs 1
- International Patents 271
- Patent Applications 2
Table of Contents
Disclaimer